Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability

Cardiovascular Research

Volumn 73, Issue 3, 2007, Pages 470-480

  Schrijvers, Dorien M ^a   De Meyer, Guido R Y ^a   Herman, Arnold G ^a   Martinet, Wim ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Apoptosis; Atherosclerosis; Lipoproteins; Phagocytosis; Plague stability

Indexed keywords

LIPOPROTEIN;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; AUTOPHAGY; CELL SURVIVAL; CELLULAR STRESS RESPONSE; ERYTHROCYTE; ERYTHROPHAGOCYTOSIS; HUMAN; MACROPHAGE; MACROPHAGE FUNCTION; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; RUPTURE; SMOOTH MUSCLE FIBER; THROMBOCYTE;

ANIMALS; ATHEROSCLEROSIS; AUTOPHAGY; BLOOD PLATELETS; CORONARY VESSELS; DISEASE PROGRESSION; ERYTHROCYTES; HUMANS; LIPOPROTEINS; MACROPHAGES; MUSCLE, SMOOTH, VASCULAR; PHAGOCYTOSIS;

EID: 33846108367     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2006.09.005     Document Type: Review

References (91)

1. Williams K.J., and Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15 (1995) 551-561
2. Kolodgie F.D., Gold H.K., Burke A.P., Fowler D.R., Kruth H.S., Weber D.K., et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349 (2003) 2316-2325
3. Aderem A., and Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17 (1999) 593-623
4. Crawford D.W., and Blankenhorn D.H. Arterial wall oxygenation, oxyradicals, and atherosclerosis. Atherosclerosis 89 (1991) 97-108
5. Wada Y., Sugiyama A., Yamamoto T., Naito M., Noguchi N., Yokoyama S., et al. Lipid accumulation in smooth muscle cells under LDL loading is independent of LDL receptor pathway and enhanced by hypoxic conditions. Arterioscler Thromb Vasc Biol 22 (2002) 1712-1719
6. Brown M.S., and Goldstein J.L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 52 (1983) 223-261
7. Goldstein J.L., Ho Y.K., Basu S.K., and Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 76 (1979) 333-337
8. Steinberg D., and Lewis A. Conner memorial lecture. Oxidative modification of LDL and atherogenesis. Circulation 95 (1997) 1062-1071
9. Khoo J.C., Miller E., McLoughlin P., and Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis 8 (1988) 348-358
10. Yuan X.M., Brunk U.T., and Olsson A.G. Effects of iron- and hemoglobin-loaded human monocyte-derived macrophages on oxidation and uptake of LDL. Arterioscler Thromb Vasc Biol 15 (1995) 1345-1351
11. Aviram M., Maor I., Keidar S., Hayek T., Oiknine J., Bar-EL Y., et al. Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated. Biochem Biophys Res Commun 216 (1995) 501-513
12. Maor I., Hayek T., Hirsch M., Iancu T.C., and Aviram M. Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice. Atherosclerosis 150 (2000) 91-101
13. Matsuura E., Kobayashi K., Inoue K., Lopez L.R., and Shoenfeld Y. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis. Lupus 14 (2005) 736-741
14. Schonbeck U., Gerdes N., Varo N., Reynolds R.S., Horton D.B., Bavendiek U., et al. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation 106 (2002) 2888-2893
15. Ramprasad M.P., Terpstra V., Kondratenko N., Quehenberger O., and Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A 93 (1996) 14833-14838
16. Kume N., Murase T., Moriwaki H., Aoyama T., Sawamura T., Masaki T., et al. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 83 (1998) 322-327
17. Miller Y.I., Viriyakosol S., Binder C.J., Feramisco J.R., Kirkland T.N., and Witztum J.L. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem 278 (2003) 1561-1568
18. Llorente-Cortes V., and Badimon L. LDL receptor-related protein and the vascular wall: implications for atherothrombosis. Arterioscler Thromb Vasc Biol 25 (2005) 497-504
19. Kruth H.S. Sequestration of aggregated low-density lipoproteins by macrophages. Curr Opin Lipidol 13 (2002) 483-488
20. Jessup W., and Kritharides L. Metabolism of oxidized LDL by macrophages. Curr Opin Lipidol 11 (2000) 473-481
21. Martinet W., and Kockx M.M. Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation. Curr Opin Lipidol 12 (2001) 535-541
22. Asmis R., Begley J.G., Jelk J., and Everson W.V. Lipoprotein aggregation protects human monocyte-derived macrophages from OxLDL-induced cytotoxicity. J Lipid Res 46 (2005) 1124-1132
23. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
24. Moreau M., Brocheriou I., Petit L., Ninio E., Chapman M.J., and Rouis M. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. Circulation 99 (1999) 420-426
25. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., and Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98 (1996) 2572-2579
26. Fazio S., Major A.S., Swift L.L., Gleaves L.A., Accad M., Linton M.F., et al. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J Clin Invest 107 (2001) 163-171
27. Nissen S.E., Tuzcu M., Brewer B., Sipahi I., Nicholls S.J., Ganz P., et al. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med 354 (2006) 1253-1263
28. Fazio S., and MacRae F.L. Failure of ACAT inhibition to retard atherosclerosis. N Engl J Med 354 (2006) 1307-1309
29. Bjorkerud S., and Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol 149 (1996) 367-380
30. Tabas I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler Thromb Vasc Biol 25 (2005) 2255-2264
31. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101 (1998) 890-898
32. Savill J., and Fadok V. Corpse clearance defines the meaning of cell death. Nature 407 (2000) 784-788
33. Grainger D.J., Reckless J., and McKilligin E. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol 173 (2004) 6366-6375
34. Chung E.Y., Kim S.J., and Ma X.J. Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res 16 (2006) 154-161
35. Maderna P., and Godson C. Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim Biophys Acta 1639 (2003) 141-151
36. deCathelineau A.M., and Henson P.M. The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem 39 (2003) 105-117
37. Fadok V.A., and Henson P.M. Apoptosis: getting rid of the bodies. Curr Biol 8 (1998) R693-R695
38. Ravichandran K.S. "Recruitment signals" from apoptotic cells: invitation to a quiet meal. Cell 113 (2003) 817-820
39. Callahan M.K., Williamson P., and Schlegel R.A. Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic thymocytes. Cell Death Differ 7 (2000) 645-653
40. Denecker G., Dooms H., Van Loo G., Vercammen D., Grooten J., Fiers W., et al. Phosphatidyl serine exposure during apoptosis precedes release of cytochrome c and decrease in mitochondrial transmembrane potential. FEBS Lett 465 (2000) 47-52
41. Hoffmann P.R., deCathelineau A.M., Ogden C.A., Leverrier Y., Bratton D.L., Daleke D.L., et al. Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells. J Cell Biol 155 (2001) 649-659
42. Krahling S., Callahan M.K., Williamson P., and Schlegel R.A. Exposure of phosphatidylserine is a general feature in the phagocytosis of apoptotic lymphocytes by macrophages. Cell Death Differ 6 (1999) 183-189
43. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A., and Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405 (2000) 85-90
44. Li M.O., Sarkisian M.R., Mehal W.Z., Rakic P., and Flavell R.A. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302 (2003) 1560-1563
45. Pradhan D., Krahling S., Williamson P., and Schlegel R.A. Multiple systems for recognition of apoptotic lymphocytes by macrophages. Mol Biol Cell 8 (1997) 767-778
46. Chang M.K., Bergmark C., Laurila A., Horkko S., Han K.H., Friedman P., et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A 96 (1999) 6353-6358
47. Sambrano G.R., Terpstra V., and Steinberg D. Independent mechanisms for macrophage binding and macrophage phagocytosis of damaged erythrocytes. Evidence of receptor cooperativity. Arterioscler Thromb Vasc Biol 17 (1997) 3442-3448
48. Palinski W., Tangirala R.K., Miller E., Young S.G., and Witztum J.L. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 15 (1995) 1569-1576
49. Shaw P.X., Horkko S., Tsimikas S., Chang M.K., Palinski W., Silverman G.J., et al. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler Thromb Vasc Biol 21 (2001) 1333-1339
50. Schrijvers D.M., De Meyer G.R.Y., Kockx M.M., Herman A.G., and Martinet W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol 25 (2005) 1256-1261
51. Moller W., Hofer T., Ziesenis A., Karg E., and Heyder J. Ultrafine particles cause cytoskeletal dysfunctions in macrophages. Toxicol Appl Pharmacol 182 (2002) 197-207
52. Arai S., Shelton J.M., Chen M., Bradley M.N., Castrillo A., Bookout A.L., et al. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab 1 (2005) 201-213
53. Hanayama R., Tanaka M., Miwa K., Shinohara A., Iwamatsu A., and Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 417 (2002) 182-187
54. Su Y.R., Dove D.E., Major A.S., Hasty A.H., Boone B., Linton M.F., et al. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1. Circulation 111 (2005) 2373-2381
55. Wiegand U.K., Corbach S., Prescott A.R., Savill J., and Spruce B.A. The trigger to cell death determines the efficiency with which dying cells are cleared by neighbours. Cell Death Differ 8 (2001) 734-746
56. Kadl A., Bochkov V.N., Huber J., and Leitinger N. Apoptotic cells as sources for biologically active oxidized phospholipids. Antioxid Redox Signal 6 (2004) 311-320
57. Mallat Z., Hugel B., Ohan J., Leseche G., Freyssinet J.M., and Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99 (1999) 348-353
58. Casciola-Rosen L., Rosen A., Petri M., and Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A 93 (1996) 1624-1629
59. Tedgui A., and Mallat Z. Apoptosis as a determinant of atherothrombosis. Thromb Haemost 86 (2001) 420-426
60. Roos A., Xu W., Castellano G., Nauta A.J., Garred P., Daha M.R., et al. A pivotal role for innate immunity in the clearance of apoptotic cells. Eur J Immunol 34 (2004) 921-929
61. Boisvert W.A., Rose D.M., Boullier A., Quehenberger O., Sydlaske A., Johnson K.A., et al. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol 26 (2006) 563-569
62. Szondy Z., Sarang Z., Molnar P., Nemeth T., Piacentini M., Mastroberardino P.G., et al. Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells. Proc Natl Acad Sci U S A 100 (2003) 7812-7817
63. Aprahamian T., Rifkin I., Bonegio R., Hugel B., Freyssinet J.M., Sato K., et al. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med 199 (2004) 1121-1131
64. Jeziorska M., and Wooley D.E. Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries. J Pathol 188 (1999) 189-196
65. Kaartinen M., Penttila A., and Kovanen P.T. Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage. Atherosclerosis 123 (1996) 123-131
66. Sambrano G.R., Parthasarathy S., and Steinberg D. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein. Proc Natl Acad Sci U S A 91 (1994) 3265-3269
67. Kockx M.M., Cromheeke K.M., Knaapen M.W., Bosmans J.M., De Meyer G.R.Y., Herman A.G., et al. Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 23 (2003) 440-446
68. Loegering D.J., Raley M.J., Reho T.A., and Eaton J.W. Macrophage dysfunction following the phagocytosis of IgG-coated erythrocytes: production of lipid peroxidation products. J Leukoc Biol 59 (1996) 357-362
69. Raley M.J., and Loegering D.J. Role of an oxidative stress in the macrophage dysfunction caused by erythrophagocytosis. Free Radic Biol Med 27 (1999) 1455-1464
70. Yuan X.M., Anders W.L., Olsson A.G., and Brunk U.T. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. Atherosclerosis 124 (1996) 61-73
71. Lee F.Y., Lee T.S., Pan C.C., Huang A.L., and Chau L.Y. Colocalization of iron and ceroid in human atherosclerotic lesions. Atherosclerosis 138 (1998) 281-288
72. Tedgui A., and Mallat Z. Platelets in atherosclerosis: a new role for beta-amyloid peptide beyond Alzheimer's disease. Circ Res 90 (2002) 1145-1146
73. Curtiss L.K., Dyer C.A., Banka C.L., and Black A.S. Platelet-mediated foam cell formation in atherosclerosis. Clin Invest Med 13 (1990) 189-195
74. De Meyer Y., De Cleen D.M., Cooper S., Knaapen M.W., Jans D.M., Martinet W., et al. Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis. Circ Res 90 (2002) 1197-1204
75. Jans D.M., Martinet W., Van De Parre T.J.L., Herman A.G., Bult H., Kockx M.M., et al. Processing of amyloid precursor protein as a biochemical link between atherosclerosis and Alzheimer's disease. Cardiovasc Haematol Disord Drug Targets 6 (2006) 21-34
76. Gozuacik D., and Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23 (2004) 2891-2906
77. Martinet W., De Meyer G.R.Y., Andries L., Herman A.G., and Kockx M.M. Detection of autophagy in tissue by standard immunohistochemistry - possibilities and limitations. Autophagy 2 (2006) 55-57
78. Kockx M.M., De Meyer G.R.Y., Buyssens N., Knaapen M.W., Bult H., and Herman A.G. Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circ Res 83 (1998) 378-387
79. Kockx M.M., De Meyer G.R.Y., Muhring J., Jacob W., Bult H., and Herman A.G. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97 (1998) 2307-2315
80. Stehbens W.E. Cerebral atherosclerosis. Intimal proliferation and atherosclerosis in the cerebral arteries. Arch Pathol 99 (1975) 582-591
81. Kockx M.M., and Herman A.G. Apoptosis in atherosclerosis: beneficial or detrimental?. Cardiovasc Res 45 (2000) 736-746
82. Kockx M.M., De Meyer G.R.Y., Bortier H., De Meyere N., Muhring J., Bakker A., et al. Luminal foam cell accumulation is associated with smooth muscle cell death in the intimal thickening of human saphenous vein grafts. Circulation 94 (1996) 1255-1262
83. Martinet W., De Bie M., Schrijvers D.M., De Meyer G.R.Y., Herman A.G., and Kockx M.M. 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24 (2004) 2296-2301
84. Knaapen M.W., Davies M.J., De Bie M., Haven A.J., Martinet W., and Kockx M.M. Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res 51 (2001) 304-312
85. Kostin S., Pool L., Elsasser A., et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 92 (2003) 715-724
86. Baehrecke E.H. Autophagy: dual roles in life and death?. Nat Rev Mol Cell Biol 6 (2005) 505-510
87. Morimoto K., Janssen W.J., Fessler M.B., McPhillips K.A., Borges V.M., Bowler R.P., et al. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol 176 (2006) 7657-7665
88. Hodge S, Hodge G, Brozyna S, Jersmann H, Holmes M, Reynolds PN. Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur Respir J; in press.
89. Godson C., Mitchell S., Harvey K., Petasis N.A., Hogg N., and Brady H.R. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 164 (2000) 1663-1667
90. de Almeida C.J., and Linden R. Phagocytosis of apoptotic cells: a matter of balance. Cell Mol Life Sci 62 (2005) 1532-1546
91. Cuervo A.M. Autophagy: in sickness and in health. Trends Cell Biol 14 (2004) 70-77